Company Profile

Glory Pharmaceuticals is a Biopharmaceutical Company focused on the development of a revolutionary medicine that prevents and treats cancer. It was found by Dr. Zheng Xu, in 1994. Since its inception, the professional medical team at Glory has continuously endeavored to improve cancer treatment using its innovative medicine and advanced technology.

The company's proprietary biological medicine -Cytotropic Heterogeneous Molecular Lipids was invented by Dr. Zheng Xu, with assistance from a group of scientists in various biological and medical fields. During the past 30+ years, numerous studies have been conducted with cellular, animal, pre-clinical and clinical trials. The advanced technology that was used to develop CHML is based upon the discovery of a biological compound, which has demonstrated the ability to induce selective apoptosis, or programmed cell death, in pre cancerous and cancerous cells. Laboratory experiments and clinical trials have shown effective results of CHML in destroying cancerous cells while exhibiting minimal toxicity to normal body cells.

CHML obtained its first patent in the United States in 1993. Thereafter, it has also acquired patents in Europe and Asia, in countries including Switzerland, France, Germany, Japan and the People's Republic of China. Currently, the company is in the final stage of obtaining production licensing in China. Glory is now focusing on the preparation of a United States Food & Drug Administration (FDA) drug registration application.

With the continuous effort to improve our medicine and treatment methodology, Glory believes that CHML has the potential to re-shape the palliative based treatment goals of today's oncologist, in a broad range of life-threatening malignant disorders.

Mission Statement

Provide more effective, less toxic therapies, for the treatment and prevention of cancer.

The primary goal of the company is one that seeks to restore hope and health to individuals currently living with the label of - incurable. Our research has enabled us to personally witness these previously "incurable" cancers become dormant and extinct.

The reality of an acute need for new weapons in the war against cancer provides daily inspiration to operate with a sense of urgency. This perception is one that individuals affected by this disease, have come to depend on.

At Glory Pharmaceuticals, we continue the fight everyday - for every tomorrow!